Glucose Health, Inc. (OTCMKTS:GLUC) Sees Large Increase in Short Interest

Glucose Health, Inc. (OTCMKTS:GLUC) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 888 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 26,004 shares, the days-to-cover ratio is currently 0.0 days.

Key Headlines Impacting Glucose Health

Here are the key news stories impacting Glucose Health this week:

• Positive Sentiment: Several articles reinforce consumer interest in blood-sugar management, including high-protein snacks, sardines, walking, meal sequencing, and dietary choices such as fruit, pasta sauce, and peanut-butter toast. This broad health focus could support long-term awareness of products positioned around glucose support, although no direct benefit to GLUC’s sales is reported. 9 High-Protein Snacks Dietitians Recommend for Better Blood Sugar Walking This Way May Lower Your Type 2 Diabetes Risk by up to 39%
• Neutral Sentiment: Coverage highlights diabetes education and disease-management resources, including a free community workshop, recommended nutrition resources, and a report that lifestyle changes helped some patients achieve type 2 diabetes remission. These items may increase public attention to the category but do not mention Glucose Health or its products. The 4 Best Nutritional Resources of 2026 for People With Diabetes Free Healthy Living With Diabetes Workshop
• Neutral Sentiment: Other reports examine blood-sugar responses to oranges versus sumo citrus, grapes versus raisins, sourdough, and normal glucose fluctuations, as well as research into biological mechanisms linking liver and pancreas dysfunction. The findings are informational rather than commercial and offer no identifiable near-term catalyst for GLUC. Oranges vs. Sumo Citrus A Little Blood Sugar Fluctuation May Not Be a Bad Thing
• Negative Sentiment: A newly introduced HemaBalance blood-sugar dietary supplement represents additional competition in the broader glucose-support market. The announcement does not indicate any relationship with GLUC, but increased supplement offerings could make customer acquisition more challenging. Hema Balance Blood Optimizer Introduces HemaBalance Capsules

Glucose Health Stock Performance

OTCMKTS:GLUC traded down $0.12 during trading hours on Wednesday, hitting $0.31. The stock had a trading volume of 175 shares, compared to its average volume of 21,669. The business’s 50 day moving average is $0.35 and its 200-day moving average is $0.38. The company has a market cap of $8.50 million, a price-to-earnings ratio of -10.33 and a beta of 1.10. Glucose Health has a one year low of $0.02 and a one year high of $0.67.

Glucose Health (OTCMKTS:GLUC) last announced its earnings results on Friday, August 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.04 million during the quarter.

Glucose Health Company Profile

Glucose Health, Inc is a consumer health company focused on developing and marketing nutritional products intended to support healthy blood glucose levels and metabolic wellness. The company’s offerings are positioned as dietary supplements and functional nutrition products rather than prescription medicines.

Its principal product has been GlucoDown, a powdered drink mix marketed for use as part of a daily wellness routine. The product is formulated with nutritional ingredients intended to support blood sugar management, and is sold directly to consumers through online channels.

Publicly available information about Glucose Health’s operating history, geographic reach, and current leadership is limited.